SeLux Diagnostics
Charlestown
About SeLux Diagnostics
SeLux Diagnostics is a developer of the next-generation phenotyping platform that provides personalized antimicrobial therapies to patients. The company is revolutionizing patient care by expediting the selection of personalized antimicrobial therapy for all infectious disease patients. This advancement will save lives, reduce hospital stays, and address the escalating antibiotic resistance epidemic by minimizing the overuse of broad-spectrum agents.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $220.5M
- Funding stage: Late Stage Venture
- Last round: Series D (Apr 2024)
- Website: seluxdx.com
- Phone: 617-945-9383
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/selux-diagnostics-42086 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.